Tuberculosis: Treatment and prevention 3 Flashcards
(33 cards)
MoA for clofazimine
Membrane destabilisation
Reactive species
MoA for PAS
Mycobactin (decreased iron uptake)
Inhibition of folic acid synthesis
MoA of Bedaquiline
ATP synthase
MoA of ethambutol
Cell wall sythesis
MoA of meropenem imipenem amoxicillin, clauvulanic acid and cycloserine terizidone
Inhibition of peptidoglycan synthesis
MoA of isoniazid
Protiomide
Ethionamide
Mycolic acid biosynthesis
MoA of PA-824 Delamanid
Reactive species a
Mycolic acid biosynthesis
MoA of moxifloxacin
Gatilofloxacin
Ofloxacin
DNA gyrase
MoA of rifampicine and rifabutin
Inhibition of RNA synthesis
MoA of linezolid, sutezolid AZD5847, Amikacin, kanamycin, capreomycin, clarithromycin
Ribosome-inhibit protein synthesis
Bedaquiline increases risk of what?
Increased risk of mortality
MoA of bedaquiline
Ihibits mycobacterial ATP synthase
Pks of bedaquiline: metabolism
PKs: metabolised by CYP3A4 need LFT monitoring (ALT, AST, bili)
DI for dedaquiline
DI: CYP3A4 inhibitors / inducers, hepatotoxic drugs.
DI: fluoroquinolones, macrolides, clofazimine, diseases
Major adverse effects of bedaquiline
Major adverse effects: QT prolongation (ECG monitoring – stop if
>500ms)
MoA od terizidone
MOA: Inhibits peptidoglycan synthesis
Distribution of Terizidone
- Widely distributed including CSF
The major effects and DI for Terizidone
Major adverse effects:
* Peripheral neuropathy (treat with pyridoxine or amitriptyline)
* DI: isoniazid
* Seizures, anxiety, depression, psychosis
* CI: psychiatric disorders / symptoms
Pks of clofazimine
- Pharmacokinetics:
- Accumulate in tissues: fat, skin, liver, kidneys and reticulo-endothelial cells – cause
red-brown pigmentation of conjunctiva and skin; may impart red colour to urine,
sweat, tears, sputum - Eliminated in bile and faeces
Adverse effects of Clofazimine and DI
Adverse effects: common - red/brown pigmentation of conjunctiva and skin
and body fluids
* QT prolongation
* DI: fluoroquinolones, macrolides, bedaquiline
what to monitor when using clofazimine
Monitor hepatic function
counselling for clofazimine
- Counselling: take with food to diminish GI upset
Delamanid is used for which age group and monitor what?
Children 3-6 years (monitor for neuropsychiatric adverse effects:
insomnia, hallucinations, night terrors)
Major advese effects of Delamanid and DI and counselling
Major adverse effects:
* Common, nausea, vomiting and dizziness
* QT prolongation (discontinue if QTcF is >500ms or ventricular
arrhythmia)
* DI: fluoroquinolones, macrolides, bedaquiline, clofazimine
* DI – hepatotoxic drugs & CYP3A4 inhibitors
* Counselling: take with food to diminish GI upset